Proton Pump Inhibitors (PPIs), Low Magnesium, and Risk of Heart Disease

Authors

Adam M. Kaye, University of the PacificFollow

ORCiD

Adam M. Kaye: 0000-0002-7224-3322

Document Type

Blog Post

Publication Title

RxEconsult, LLC

Publication Date

5-8-2013

Abstract

Pharmacists have recently learned about the interaction between proton pump inhibitors (PPIs) and Plavix (clopidogrel). Is it possible that a simple drug that reduces acid could really reduce the efficacy of a powerful anti-platelet medication? What if the patient is at risk for a GI bleed? What if the patient is also on aspirin? The debate is ongoing.

Recommended Citation

Kaye, A. M. (2013). Proton Pump Inhibitors (PPIs), Low Magnesium, and Risk of Heart Disease. RxEconsult, LLC, ,
https://scholarlycommons.pacific.edu/phs-facarticles/652